Bio-Techne (TECH) Revenue — Quarter Ended Dec 31, 2024
Revenue for the reported quarter increased compared to both the immediately preceding quarter and the same quarter one year earlier. The company's top line continued its growth trend.
Key takeaway
Quarter ended Dec 31, 2024 · FY2025 Q2
Revenue for the reported quarter increased compared to both the immediately preceding quarter and the same quarter one year earlier. The company's top line continued its growth trend.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$297M
Revenue reported for this quarter.
Quarter-over-quarter
+2.6%
Change from the immediately preceding quarter.
Year-over-year
+9.0%
Change from the comparable year-ago quarter.
Trailing four quarters
$1.2B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Mar 31, 2024 | $303.4M | +3.2% |
| Jun 30, 2024 | $306.1M | +1.6% |
| Sep 30, 2024 | $289.5M | +4.5% |
| Dec 31, 2024 | $297M | +9.0% |
Revenue performance
The revenue performance reflects a sequential improvement and a more substantial year-over-year increase.
Quarterly comparison
Sequentially, revenue grew from the immediately preceding quarter. On an annual basis, revenue was significantly higher than the same period last year.
What to watch
The company has a contractual obligation to acquire the remaining interest in Wilson Wolf by a future date, which may be accelerated if certain financial milestones are achieved.